|Articles|November 15, 2003

NEI to test intraocular implant to thwart RP

Paris-Neurotech SA is initiating a phase I clinical trial of NT-501, its lead Encapsulated Cell Technology (ECT) product for the treatment of retinitis pigmentosa (RP).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME